Lexicon Pharmaceuticals, Inc. (LXRX)

Last Closing Price: 0.66 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Lexicon Pharmaceuticals, Inc. (LXRX) had Net Income of $-25.30M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$1.26M
Net Income
$-25.30M
$0.03M
$1.23M
$26.94M
$-25.68M
$0.38M
$-25.30M
$-25.30M
$-25.30M
$-25.30M
$-25.30M
$-25.30M
$-25.68M
$-25.10M
362.07M
362.07M
$-0.07
$-0.07
Balance Sheet Financials
$245.81M
$2.31M
$51.87M
$297.67M
$110.69M
$58.64M
$63.95M
$174.64M
$123.03M
$78.49M
$123.03M
363.18M
Cash Flow Statement Financials
$-43.78M
$40.58M
$-0.57M
$66.66M
$62.89M
$-3.77M
$3.04M
--
--
Fundamental Metrics & Ratios
2.22
--
--
0.32
0.82
97.62%
-2034.79%
-2034.79%
--
-2004.36%
-2004.36%
$-43.78M
--
--
--
0.00
0.15
0.03
3383.70
-20.56%
-32.23%
-8.50%
-13.92%
$0.34
$-0.12
$-0.12